Founder, CEO & Director
Alexandra has had deep exposure to innovation and entrepreneurship in the medical technology, biometric data, and sports telemetry systems. Having had sinonasal issues for her entire adult life, she has an intimate understanding of the concerns, issues and opportunities in the industry.
Emeritus Professor William Coman
AM MD, FRCS, FRCS, FRACS, FACS, Foundation Chair of The Garnett Passe and Rodney Williams Memorial Foundation
"Bill was appointed as Consultant ENT Surgeon to the Princess Alexandra Hospital, also serving as the GPRWMF Professor of Otolaryngology, Head and Neck Surgery from 1999 to 2011. During this time he organised overseas training for Australian registrars at Oxford, Bristol, St Bartholemew’s and Guys Hospital London, John Hopkins University USA, University of Virginia, University of Iowa, University of Vermont, New York and Lund University in Sweden. Some 36 overseas Fellows and researchers have worked in the Department of Otolaryngology, Head and Neck Surgery, under his patronage at the University of Queensland and Griffith University, where he also served as Professor Otolaryngology, Head and Neck Surgery. He has supervised and mentored over a dozen PhD students throughout his career." Bill has an wide array of accolades that span from research, innovation in medicine, service to industry and much more.
Extract from he Garnett Passe and Rodney Williams Memorial FoundationWebsite, February 2019
Dr Caroline Herd
CEO of QID Pharma Pty Ltd, Director and Principal of Quorom Solutions Pty Ltd
"Caroline is a co-founder of QID Pharma and as the founding CEO is responsible for the overall company strategy encompassing new product development initiatives. With more than 25 years experience in academia and the pharma and biotech industry, that included clinical development positions at Astra-Zeneca in Europe and significant senior leadership roles at Metabolic Pharmaceuticals and Prana Biotechnology in Australia, both ASX listed companies, Caroline was responsible for the regulatory and development strategy and implementation across a range of therapeutic areas." Extract from QID Pharma Website, February 2019